JP2015129652A5 - - Google Patents

Download PDF

Info

Publication number
JP2015129652A5
JP2015129652A5 JP2014000417A JP2014000417A JP2015129652A5 JP 2015129652 A5 JP2015129652 A5 JP 2015129652A5 JP 2014000417 A JP2014000417 A JP 2014000417A JP 2014000417 A JP2014000417 A JP 2014000417A JP 2015129652 A5 JP2015129652 A5 JP 2015129652A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
sequence shown
peptide consisting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014000417A
Other languages
English (en)
Japanese (ja)
Other versions
JP6312302B2 (ja
JP2015129652A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014000417A priority Critical patent/JP6312302B2/ja
Priority claimed from JP2014000417A external-priority patent/JP6312302B2/ja
Publication of JP2015129652A publication Critical patent/JP2015129652A/ja
Publication of JP2015129652A5 publication Critical patent/JP2015129652A5/ja
Application granted granted Critical
Publication of JP6312302B2 publication Critical patent/JP6312302B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014000417A 2014-01-06 2014-01-06 脳梗塞の診断マーカー Active JP6312302B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014000417A JP6312302B2 (ja) 2014-01-06 2014-01-06 脳梗塞の診断マーカー

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014000417A JP6312302B2 (ja) 2014-01-06 2014-01-06 脳梗塞の診断マーカー

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018050502A Division JP6499342B2 (ja) 2018-03-19 2018-03-19 脳梗塞の診断マーカー

Publications (3)

Publication Number Publication Date
JP2015129652A JP2015129652A (ja) 2015-07-16
JP2015129652A5 true JP2015129652A5 (fr) 2017-06-22
JP6312302B2 JP6312302B2 (ja) 2018-04-18

Family

ID=53760486

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014000417A Active JP6312302B2 (ja) 2014-01-06 2014-01-06 脳梗塞の診断マーカー

Country Status (1)

Country Link
JP (1) JP6312302B2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6942036B2 (ja) * 2017-11-30 2021-09-29 藤倉化成株式会社 脳梗塞の発症リスクを高感度に検出する体液抗体バイオマーカー
CN114594273B (zh) * 2022-05-09 2024-02-27 上海众启生物科技有限公司 一种脑梗塞生物标记物及其应用
CN115261457B (zh) * 2022-06-13 2023-10-27 广州市妇女儿童医疗中心 用于辅助诊断脑梗塞及其预后评价的标志物组合及含有其的试剂盒与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4070443B2 (ja) * 2001-10-11 2008-04-02 株式会社三菱化学ヤトロン 脳梗塞を検出する方法
GB0911060D0 (en) * 2009-06-26 2009-08-12 Ge Healthcare Uk Ltd Methods for predicting the toxicity of a chemical
CN103299191B (zh) * 2010-08-13 2016-06-15 莫尔豪斯医学院 中风的生物标记
WO2012051519A2 (fr) * 2010-10-14 2012-04-19 The Johns Hopkins University Biomarqueurs d'une lésion cérébrale
GB2497138A (en) * 2011-12-02 2013-06-05 Randox Lab Ltd Biomarkers for stroke and stroke subtype diagnosis.
JP6276252B2 (ja) * 2012-03-26 2018-02-07 イェダ リサーチ アンド ディベロップメント カンパニー リミテッドＹｅｄａ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｄｅｖｅｌｏｐｍｅｎｔ Ｃｏ． Ｌｔｄ アルツハイマー病の診断のための細胞マーカーおよびアルツハイマー病の進行の細胞マーカー

Similar Documents

Publication Publication Date Title
JP2017048194A5 (fr)
JP2013172734A5 (fr)
WO2017011820A3 (fr) Peptides inhibiteurs du récepteur de l'interleukine-23 et leur utilisation pour traiter des maladies inflammatoires
WO2016115168A8 (fr) Incorporation de nucléotides non naturels et procédés associés
MX2018001213A (es) Nuevos metodos para inducir una respuesta inmunitaria.
MX2017009595A (es) Compuestos antisenescentes y usos de los mismos.
IL251571B (en) Variable proteins comprising the cry1da1 amino acid sequence are activated by lepidopteran
WO2016115320A8 (fr) Nanostructructures d'acides nucléiques pourvues de motifs de noyau
WO2017025179A8 (fr) Marqueur transglutamine pour une bioconjugaison efficace spécifique à un site
WO2015107363A3 (fr) Composition d'antigène mycobactérien
IL250646A0 (en) A process for conjugating a peptide or protein with a reagent containing a leaving group that includes a peg moiety
DOP2016000202A (es) Proteínas de fusión uti
JP2010265269A5 (fr)
JP2015129652A5 (fr)
CU20170038A7 (es) Derivados de adrenomedulina estabililzados especialmente útiles en el tratamiento y/o prevención de trastornos cardiovasculares, edematosos y/o inflamatorios
WO2016150415A8 (fr) Peptides se liant spécifiquement à des espèces a-bêta pour la thérapie et/ou le diagnostic de la démence d'alzheimer
WO2015143339A3 (fr) Liants d'hémagglutinine de grippe améliorés
ES2609993B1 (es) Péptido para el tratamiento de la alergia
WO2016205522A3 (fr) Anticorps reconnaissant la phosphorylation sur des résidus acides aminés spécifiques de la protéine 43 de la réponse transactive se liant à l'adn
TH168562B (th) กรดนิวคลีอิกและวิธีการสำหรับการตรวจหาเชื้อก่อโรคและจุลินทรีย์ที่เป็นประโยชน์
TH168562A (th) กรดนิวคลีอิกและวิธีการสำหรับการตรวจหาเชื้อก่อโรคและจุลินทรีย์ที่เป็นประโยชน์
RU2016146358A (ru) Ингибитор холинорецептора
TH168983A (th) แคทไอออนิค นิวโรทอกซิน (Cationic Neurotoxins)
Win The Yati (Vol 11 No 128) 2014/11
TH177981A (th) กระบวนการสำหรับการเตรียมกรด 3-ไฮดรอกซิพิโคลินิค